Literature DB >> 20691454

A hospital-based intermittent nocturnal hemodialysis program for children and adolescents.

Anne Hoppe1, Christina von Puttkamer, Ursula Linke, Cindy Kahler, Martina Booss, Renate Braunauer-Kolberg, Katja Hofmann, Petra Joachimsky, Ingrid Hirte, Sylke Schley, Boris Utsch, Julia Thumfart, Sonia Briese, Jutta Gellermann, Miriam Zimmering, Uwe Querfeld, Dominik Müller.   

Abstract

OBJECTIVE: To establish a hospital-based nocturnal hemodialysis (NHD) program for children and adolescents. STUDY
DESIGN: Sixteen patients (age, 0.5 to 17 years) were prospectively included. Uremia-associated measures as well as amount and dosage of medication were enumerated. Quality of life also was evaluated. Results were compared with data of the same patients on conventional hemodialysis and with matched control subjects (conventional HD).
RESULTS: NHD was well tolerated. Median Kt/V values increased. Predialytic mean arterial pressure, urea, phosphate, and parathyroid hormone levels decreased. There was an increase in protein catabolic rate. Dietary and fluid restrictions could be lifted. Amount and dosage of phosphate and potassium binders and antihypertensive medication could be reduced. Quality of life improved and days of absence from school decreased in all patients.
CONCLUSIONS: In addition to a better control of uremia-associated measures, NHD allows free dietary and fluid intake and improves patient well-being. Given the continuing shortage of donor organs for kidney transplantation and the high morbidity and mortality on conventional HD, intensified dialysis regimens are a much-needed therapeutic option.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20691454     DOI: 10.1016/j.jpeds.2010.06.036

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

1.  Is peritoneal dialysis still an equal option? Results of the Berlin pediatric nocturnal dialysis program.

Authors:  Julia Thumfart; Tanja Hilliger; Christina Stiny; Steffen Wagner; Uwe Querfeld; Dominik Müller
Journal:  Pediatr Nephrol       Date:  2015-01-27       Impact factor: 3.714

Review 2.  Hypertension and hemodialysis: pathophysiology and outcomes in adult and pediatric populations.

Authors:  Peter N Van Buren; Jula K Inrig
Journal:  Pediatr Nephrol       Date:  2011-02-01       Impact factor: 3.714

Review 3.  Hypertension in Pediatric Dialysis Patients: Etiology, Evaluation, and Management.

Authors:  Raj Munshi; Joseph T Flynn
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

Review 4.  Intensified hemodialysis in adults, and in children and adolescents.

Authors:  Julia Thumfart; Wolfgang Pommer; Uwe Querfeld; Dominik Müller
Journal:  Dtsch Arztebl Int       Date:  2014-04-04       Impact factor: 5.594

Review 5.  Nutrition and growth in children with chronic kidney disease.

Authors:  Lesley Rees; Robert H Mak
Journal:  Nat Rev Nephrol       Date:  2011-09-27       Impact factor: 28.314

Review 6.  Cardiovascular disease in children with chronic kidney disease.

Authors:  Mark M Mitsnefes
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

Review 7.  Nutritional management and growth in children with chronic kidney disease.

Authors:  Lesley Rees; Helen Jones
Journal:  Pediatr Nephrol       Date:  2012-07-24       Impact factor: 3.714

Review 8.  Pubertal development in children with chronic kidney disease.

Authors:  Dieter Haffner; Miroslav Zivicnjak
Journal:  Pediatr Nephrol       Date:  2016-07-27       Impact factor: 3.714

Review 9.  Nocturnal intermittent hemodialysis.

Authors:  Julia Thumfart; Dominik Müller
Journal:  Pediatr Nephrol       Date:  2014-08-08       Impact factor: 3.714

10.  Low agreement between cardiologists diagnosing left ventricular hypertrophy in children with end-stage renal disease.

Authors:  Nikki J Schoenmaker; Johanna H van der Lee; Jaap W Groothoff; Gabrielle G van Iperen; Ingrid M E Frohn-Mulder; Ronald B Tanke; Jaap Ottenkamp; Irene M Kuipers
Journal:  BMC Nephrol       Date:  2013-08-02       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.